At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FEED ENvue Medical, Inc
Trading 03-10 10:53:51 EDT
1.91
-0.02
-1.04%
High1.92
Low1.83
Vol25.93K
Open1.89
D1 Closing1.93
Amplitude4.66%
Mkt Cap2.08M
Tradable Cap2.08M
Total Shares1.09M
T/O48.50K
T/O Rate2.38%
Tradable Shares1.09M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Envue Medical Inc. Files Initial Beneficial Ownership Statement for Interim CFO Nicole M. Fernandez-McGovern
Enerflex Ltd. Announces Fourth Quarter 2025 Financial and Operational Results, Agreement to Divest Non-Core Business and Provides Preliminary Outlook for 2026
TECNIMONT (MAIRE) ENTERS THE LNG MARKET THROUGH A STRATEGIC AGREEMENT WITH ARGENT LNG IN THE USA FOR THE DEVELOPMENT OF AN LNG EXPORT FACILITY IN LOUISIANA
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.